2017
DOI: 10.4238/gmr16019481
|View full text |Cite
|
Sign up to set email alerts
|

Is differential expression of p16INK4a based on the classification of uterine smooth muscle tumors associated with a different prognosis? A meta-analysis

Abstract: ABSTRACT. We conducted a meta-analysis to examine p16INK4a expression in uterine smooth muscle tumors (USMTs). Although the prognostic value of tumor suppressor p16INK4a has been elucidated in a variety of cancers and precancerous lesions, its role in USMTs is not well established. We searched PubMed, Web of Science, and Embase for publication son p16INK4a expression in USMTs. Strict inclusion and exclusion criteria were imposed. Risk ratios (RRs) with 95% confidence intervals (95%CIs) were calculated to asses… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
6
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 24 publications
(35 reference statements)
0
6
0
Order By: Relevance
“…A recent study analyzed proteins p16, p53, Ki-67, estrogen receptor (ER), and progesterone receptor (PR) and illustrated that these proteins could be biomarkers for aggressive tissue (17). Further, expression of MIB-1, p53, and PR could be helpful for the differentiation of SMT, STUMP, and leiomyosarcoma (18)(19)(20)(21). Since the prognosis of leiomyosarcoma is much worse than that for STUMP, it is vital to determine the risk factors for relapse and leiomyosarcoma.…”
Section: Discussionmentioning
confidence: 99%
“…A recent study analyzed proteins p16, p53, Ki-67, estrogen receptor (ER), and progesterone receptor (PR) and illustrated that these proteins could be biomarkers for aggressive tissue (17). Further, expression of MIB-1, p53, and PR could be helpful for the differentiation of SMT, STUMP, and leiomyosarcoma (18)(19)(20)(21). Since the prognosis of leiomyosarcoma is much worse than that for STUMP, it is vital to determine the risk factors for relapse and leiomyosarcoma.…”
Section: Discussionmentioning
confidence: 99%
“…Recent studies have suggested the use of immunohistochemical stains, including epithelial growth factor receptor, galectin-3, p16, p16INK4a, p53, MIB-1, Twist, BCL-2, estrogen, and progesterone receptors to identify uterine smooth muscle tumors with a higher risk of recurrence [1516171819]. Although recurrent tumors regarded as STUMPs are associated with diffuse immunoreactivity for p16 and p53 [2021], the number of cases in these studies are small and further studies are needed to confirm the reliability of such markers.…”
Section: Discussionmentioning
confidence: 99%
“…Overexpression occurs in approximately 5% of leiomyomas and 50% of leiomyosarcoma [30,[33][34][35]. These figures, confirmed by a recent meta-analysis [37], suggest a negative correlation with differentiation and prognosis.…”
Section: Discussionmentioning
confidence: 88%